Notification on the change of Application fee for Product dossier assessment

August 3rd, 2017

19/DRA/DC/Notification/2016-2017/40

Regulatory Notification

DRA would like to notify that the application fee for product dossier assessment has been revised to Nu. 500 (Five hundred) based on the consensus of the stakeholders and approval from the Sixteenth meeting of the Bhutan Medicines Board. This is notification shall come into force from 03 August, 2017.

Please click on the link below to view the Notification:
Regulatory Notification for Mandatory Submission of e-dossiers and Sample Submission

April 14th, 2022
Regulatory Notification on Requirement of Emergency Use Authorization (EUA) for Import, Sale and Distribution of COVID-19 self-test kits

April 6th, 2022
Competency Examination

March 31st, 2022
Regulatory Notification on Sale, distribution and use of COVID-19 antigen self-test Kits

March 30th, 2022
WHO Bhutan handed over equipment to DRA

February 17th, 2022
Scholarship Announcement

February 13th, 2022